Using Fishbone, FMEA, and Control Strategy Maps to Define CPV Monitoring Lists Using Fishbone, FMEA, and Control Strategy Maps to Define CPV Monitoring Lists Continued Process Verification (CPV) is a systematic approach that ensures the consistent quality of pharmaceuticals throughout their lifecycle. This includes continuous monitoring and assessment of critical quality attributes (CQAs) and critical process parameters (CPPs). Employing tools like fishbone diagrams, Failure Mode and Effects Analysis (FMEA), and control strategy maps is essential for defining effective CPV monitoring lists. This article will provide a comprehensive guide to understanding and implementing these methodologies in line with regulatory expectations set…

Linking QTPP, CQAs and CPPs to CPV Parameter Selection Decisions Linking QTPP, CQAs and CPPs to CPV Parameter Selection Decisions In the evolving landscape of pharmaceutical manufacturing and quality assurance, Continued Process Verification (CPV) has emerged as a critical component for ensuring product quality and compliance with regulatory requirements. As regulatory bodies such as the FDA, EMA and MHRA focus increasingly on quality by design (QbD) principles, the integration of Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), and Critical Process Parameters (CPPs) into the CPV framework is essential for efficient lifecycle performance management. This article explores the relationships…

Risk based selection of CPV variables using process knowledge and control strategy Risk Based Selection of CPV Variables Using Process Knowledge and Control Strategy Introduction Continued Process Verification (CPV) is a crucial component of the pharmaceutical industry’s commitment to ensure quality through real-time monitoring of manufacturing processes. The selection of appropriate parameters, known as Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs), is essential for effective CPV implementation. This article focuses on the risk-based selection of CPV variables through process knowledge and control strategies, in alignment with the regulatory expectations set forth by the US FDA, EMA, and MHRA….

How to select CPV parameters CQAs and CPPs for effective monitoring How to select CPV parameters CQAs and CPPs for effective monitoring Continued Process Verification (CPV) represents a critical component of modern pharmaceutical manufacturing practices, especially as regulations and market expectations evolve. This regulatory explainer manual seeks to provide pharmaceutical professionals and clinical operations experts with a comprehensive guide on selecting CPV parameters, Critical Quality Attributes (CQAs), and Critical Process Parameters (CPPs) for effective monitoring. Our primary focus will encompass the FDA’s 21 CFR regulation alongside the European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) protocols….

Aligning CPV Parameter Selection with Annex 1 Contamination Control Strategy Aligning CPV Parameter Selection with Annex 1 Contamination Control Strategy In the biopharmaceutical industry, the imperative of ensuring product quality while minimizing contamination risks is paramount. This guideline focuses on the alignment of Continued Process Verification (CPV) parameter selection with the principles outlined in Annex 1 of the EU GMP guidelines, particularly concerning the contamination control strategy (CCS). This article is tailored for professionals engaged in regulatory affairs, quality assurance, clinical operations, and medical affairs, detailing best practices for CPV parameter selection and monitoring. Understanding Continued Process Verification Continued Process…

How to incorporate PAT and inline measurements into CPV monitoring How to incorporate PAT and inline measurements into CPV monitoring In the current pharmaceutical manufacturing landscape, regulatory bodies such as the US FDA, EMA, and MHRA emphasize the importance of Continued Process Verification (CPV) as an integral part of quality assurance frameworks. The incorporation of Process Analytical Technology (PAT) and inline measurements into CPV monitoring presents significant advantages for maintaining quality control throughout the product lifecycle. This article outlines how pharma professionals can effectively integrate PAT signals within a CPV framework while ensuring compliance with regulatory expectations. Understanding Continued Process…

CPV Parameter Selection for Sterile, Biologic and High-Risk Dosage Forms CPV Parameter Selection for Sterile, Biologic and High-Risk Dosage Forms Continued Process Verification (CPV) plays a crucial role in ensuring the quality and consistency of drug products, particularly for sterile, biologic, and high-risk dosage forms. Selection of appropriate parameters, understanding of Critical Quality Attributes (CQAs), and identification of Critical Process Parameters (CPPs) are essential components of an effective quality management system aligned with both FDA and EMA regulatory expectations. This article aims to provide a comprehensive overview of CPV parameter selection, designed for professionals navigating the complex regulatory landscapes in…

Defining primary, secondary and diagnostic CPV parameters by unit operation Defining Primary, Secondary, and Diagnostic CPV Parameters by Unit Operation Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a significant aspect of modern pharmaceutical quality management, emphasizing the need for ongoing validation of manufacturing processes to ensure product quality. With the advent of regulatory frameworks such as the FDA’s guidance on Quality by Design (QbD), and the shift towards a more proactive approach to quality assurance, understanding the selection of CPV parameters has never been more critical. This article serves as a comprehensive guide to CPV parameter…

Balancing too many vs too few parameters in CPV monitoring plans Balancing Too Many vs Too Few Parameters in CPV Monitoring Plans Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) has emerged as a critical component of the pharmaceutical manufacturing landscape, particularly in the context of ensuring product quality and compliance with regulatory standards. As outlined in the FDA’s Guidance for Industry: Process Validation: General Principles and Practices, CPV is an ongoing, continuous monitoring process designed to assure that the manufacturing process remains in a state of control throughout the product lifecycle. However, a vital question arises when…

Case Studies of Poor CPV Parameter Selection That Missed Critical Signals Case Studies of Poor CPV Parameter Selection That Missed Critical Signals Continued Process Verification (CPV) has gained significant traction in the pharmaceutical industry, enhancing product quality and compliance with regulatory expectations. However, the effective selection of CPV parameters is paramount, as improper selection can lead to missed critical signals, potentially jeopardizing product quality and patient safety. This article provides a thorough exploration of case studies that exemplify poor CPV parameter selection. We will delve into the implications of these missteps and discuss best practices in CPV parameter selection aligned…